Heritage Bio Labs
Research Library
Explore 411 articles about peptides, research compounds and related topics, with links to the original studies.
Find articles
Matching articles
Showing 25–36 of 77 articles · Interpret the evidence
- Interpret the evidence
How a cultured pituitary study separated receptor signals
GHRP-2 is a six-residue synthetic peptide also called pralmorelin. It activates the ghrelin receptor, also known as the growth hormone secretagogue receptor. How did researchers distinguish its signaling from that of the natural pituitary stimulus growth hormone–releasing hormone (GHRH)?
GHRP-22 sources (1998, 2025)
- Interpret the evidence
What the 2026 COURAGE-2 stroke trial found about a specific combination
Growth hormone–releasing peptide 6, or GHRP-6, is a synthetic six-residue peptide that activates the ghrelin receptor and can stimulate growth hormone release. In 2026, a clinical trial reported whether a combination containing GHRP-6 improved disability after acute ischemic stroke.
GHRP-62 sources (2021, 2026)
- Interpret the evidence
What an Achilles Tendon Study Can Tell Us About Two GLOW Components
GLOW is a blend label that can include BPC-157, a material called TB-500 and GHK-Cu. A 2026 study addresses the first two names in a rat model, which makes it useful for understanding the component evidence. The experiment did not test the three-component GLOW mixture.
GLOW Blend2 sources (2026)
- Interpret the evidence
What the 2026 Compounding Policy Does and Does Not Say About GLOW
GLOW is a catalog blend name, which in the formulation discussed here refers to GHK-Cu, BPC-157 and TB-500. Some of those names also appear in federal documents. Seeing a name in a policy does not establish that a commercial blend has been evaluated.
GLOW Blend2 sources (2026)
- Interpret the evidence
Why a Human Muscle Cell Study Is Not a GLOW 2 Clinical Trial
MOTS-c is a mitochondrial peptide named as one component of the catalog's GLOW 2 formulation. In 2026, Rabie Elhusseiny and colleagues tested MOTS-c in human-derived muscle cells exposed to dexamethasone, a glucocorticoid. The researchers studied one ingredient in a cell model.
GLOW 2 Blend1 source (2026)
- Interpret the evidence
How researchers compared semaglutide tablets and injections across trials
Semaglutide is a modified peptide that activates the GLP-1 receptor. It is available in FDA-approved oral and injectable products with product-specific indications.
GLP-1 SEMA2 sources (2026)
- Interpret the evidence
Why the heart outcomes trial used an active comparator
Tirzepatide activates GIP and GLP-1 receptors. The catalog wording “GLP-2 TIRZ” refers to tirzepatide and does not identify a GLP-2 target.
GLP-2 TIRZ3 sources (2022–2026)
- Interpret the evidence
What a 2026 blood study can tell us about glutathione exposure
Glutathione is a naturally occurring three-amino-acid peptide that can shift between reduced and oxidized forms. A 2026 clinical study compared several glutathione products and asked how levels of the peptide and related compounds changed in blood.
Glutathione2 sources (2014, 2026)
- Interpret the evidence
Why one hCG trigger comparison cannot answer every fertility question
Human chorionic gonadotropin (hCG) is a larger, sugar-bearing hormone formed from two amino-acid chains. In some fertility procedures, it supplies a signal that helps eggs finish maturing. A January 2026 trial compared hCG alone with a two-part trigger in women aged 35 to 42.
HCG3 sources (2023, 2026)
- Interpret the evidence
Why the Large Serelaxin Trial Did Not Confirm a Benefit in Acute Heart Failure
Human relaxin-2 is a peptide hormone involved in cardiovascular and renal adaptations during pregnancy. Serelaxin is a recombinant form of human relaxin-2.
Human Relaxin-22 sources (2019, 2026)
- Interpret the evidence
What Mouse Heart Scarring Studies Can Tell Us About Serelaxin
Human relaxin-2 is one such hormone. Researchers study its recombinant form, serelaxin, in models of fibrosis, a process in which excessive scar-like material accumulates. In the heart, fibrosis can change how tissue moves.
Human Relaxin-22 sources (2019, 2026)
- Interpret the evidence
What a 2026 cohort study found about circulating IGF-1 and epilepsy risk
Human insulin-like growth factor 1 (IGF-1) is a 70-amino-acid hormone involved in growth and metabolism. A 2026 study looked at naturally circulating IGF-1 and asked whether blood concentrations measured before a diagnosis were associated with later epilepsy.
IGF-1 Human2 sources (2026)
Browse by product
- A4 Amyloid Beta6 articles
- ACE-0316 articles
- ACE-0836 articles
- Adipotide6 articles
- AICAR6 articles
- AOD-96046 articles
- ARA-2906 articles
- BPC-1576 articles
- BPC-157 / TB-5006 articles
- Cagrilintide7 articles
- CJC-1295 (No DAC) / GHRP-26 articles
- CJC-1295 (No DAC) / GHRP-66 articles
- CJC-1295 (No DAC) / Ipamorelin6 articles
- CJC-1295 No DAC6 articles
- CJC-1295 With DAC6 articles
- DSIP6 articles
- Epitalon6 articles
- Follistatin 3156 articles
- Follistatin 3446 articles
- Fragment 176-1916 articles
- GHK-Cu6 articles
- GHRP-26 articles
- GHRP-66 articles
- GLOW 2 Blend6 articles
- GLOW Blend6 articles
- GLP-1 SEMA6 articles
- GLP-2 TIRZ6 articles
- Glutathione6 articles
- HCG6 articles
- Hexarelin6 articles
- Human Relaxin-26 articles
- IGF-1 DES 1,36 articles
- IGF-1 Human6 articles
- IGF-2 LR36 articles
- IGF-DES 1,36 articles
- IGF-LR36 articles
- Ipamorelin6 articles
- Kisspeptin-106 articles
- KLOW Blend6 articles
- KPV6 articles
- Lipopeptide6 articles
- Liraglutide6 articles
- Melanotan II5 articles
- MGF6 articles
- MOTS-C6 articles
- MSC Exosomes6 articles
- Myostatin6 articles
- Myostatin HMP (GDF8)6 articles
- Oxytocin7 articles
- PEG-MGF6 articles
- Pinealon6 articles
- PT-1416 articles
- RETA / IGF-1 LR36 articles
- RETA GLP-36 articles
- Selank6 articles
- SEMA / IGF-1 LR36 articles
- Semax6 articles
- Sermorelin6 articles
- SLU-PP-3326 articles
- SNAP-86 articles
- Survodutide7 articles
- TB-5006 articles
- Tesamorelin6 articles
- Thymosin Alpha-16 articles
- TIRZ / IGF-1 LR36 articles
- TIRZ GLP-26 articles
- Trevogrumab6 articles
- Triptorelin GnRH6 articles
